224 related articles for article (PubMed ID: 22406108)
1. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
[TBL] [Abstract][Full Text] [Related]
3. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
4. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Koenig P; Lange E; Reimann I; Beer M
Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
6. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
[TBL] [Abstract][Full Text] [Related]
7. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
8. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.
König P; Blome S; Gabriel C; Reimann I; Beer M
Vaccine; 2011 Dec; 30(1):5-8. PubMed ID: 22064266
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
Renson P; Le Dimna M; Gabriel C; Levai R; Blome S; Kulcsar G; Koenen F; Le Potier MF
Res Vet Sci; 2014 Apr; 96(2):389-95. PubMed ID: 24530018
[TBL] [Abstract][Full Text] [Related]
10. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
[TBL] [Abstract][Full Text] [Related]
15. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of classical swine fever virus infection from CP7_E2alf marker vaccination by a multiplex microsphere immunoassay.
Xia H; Harimoorthy R; Vijayaraghavan B; Blome S; Widén F; Beer M; Belák S; Liu L
Clin Vaccine Immunol; 2015 Jan; 22(1):65-71. PubMed ID: 25378351
[TBL] [Abstract][Full Text] [Related]
18. First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.
Feliziani F; Blome S; Petrini S; Giammarioli M; Iscaro C; Severi G; Convito L; Pietschmann J; Beer M; De Mia GM
Vaccine; 2014 Apr; 32(18):2050-5. PubMed ID: 24565752
[TBL] [Abstract][Full Text] [Related]
19. Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.
Lévai R; Barna T; Fábián K; Blome S; Belák K; Bálint Á; Koenen F; Kulcsár G; Farsang A
Biologicals; 2015 Mar; 43(2):92-9. PubMed ID: 25637578
[TBL] [Abstract][Full Text] [Related]
20. The double-antigen ELISA concept for early detection of E
Meyer D; Fritsche S; Luo Y; Engemann C; Blome S; Beyerbach M; Chang CY; Qiu HJ; Becher P; Postel A
Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
